Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease

Lists

Download

Preview

Am J Clin Nutr-2015-Schär-ajcn.114.104364.pdf - Published Version (196kB) | Preview

Available under license: Creative Commons Attribution

[thumbnail of FINAL_Schar_2014_flavanone RCT_18FEB2015_CLEAN revised manuscript.docx]

FINAL_Schar_2014_flavanone RCT_18FEB2015_CLEAN revised manuscript.docx - Accepted Version (124kB)

Restricted to Repository staff only

Tools

Schar, M., Curtis, P., Hazim, S., Ostertag, L., Kay, C., Potter, J. and Cassidy, A. (2015) Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease. American Journal of Clinical Nutrition, 101 (5). pp. 931-938. ISSN 0002-9165 doi: 10.3945/ajcn.114.104364

Abstract/Summary

Background: Epidemiological data suggest inverse associations between citrus flavanone intake and cardiovascular disease (CVD) risk. However, insufficient randomized controlled trial (RCT) data limit our understanding of mechanisms by which flavanones and their metabolites potentially reduce cardiovascular (CV) risk factors. Objective: We examined the effects of orange juice or a dose-matched hesperidin supplement on plasma concentrations of established and novel flavanone metabolites and their effects on CV risk biomarkers in men at moderate CVD risk. Methods: In an acute, randomized, placebo-controlled crossover trial, 16 fasted participants (aged 51-69 y) received orange juice or a hesperidin supplement (both providing 320 mg hesperidin) or control (all matched for sugar and vitamin C content). At baseline and 5 h post-intake, endothelial function (primary outcome), further CV risk biomarkers (i.e. blood pressure, arterial stiffness, cardiac autonomic function, platelet activation and NADPH oxidase gene expression) and plasma flavanone metabolites were assessed. Prior to each intervention, a diet low in flavonoids, nitrate/nitrite, alcohol and caffeine was followed and a standardized low-flavonoid evening meal was consumed. Results: Orange juice intake significantly elevated mean (± SEM) plasma concentrations of 8 flavanone (1.75 ± 0.35 µmol/L, P < 0.0001) and 15 phenolic metabolites (13.27 ± 2.22 µmol/L, P < 0.0001) compared with control at 5 h post-consumption. Despite increased plasma flavanone and phenolic metabolite concentrations, CV risk biomarkers were unaltered. Following hesperidin supplement intake, flavanone metabolites were not different to control, suggesting altered absorption/metabolism compared with the orange juice matrix. Conclusions: Following single-dose flavanone intake within orange juice, we detected circulating flavanone and phenolic metabolites collectively reaching a concentration of 15.20 ± 2.15 µmol/L but observed no effect on CV risk biomarkers. Longer-duration RCTs are required to further examine the previous associations between higher flavanone intakes and improved cardiovascular health and to ascertain the relative importance of food matrix and flavanone-derived phenolic metabolites.

Altmetric Badge

Item Type	Article
URI	https://reading-clone.eprints-hosting.org/id/eprint/39748
Item Type	Article
Refereed	Yes
Divisions	Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences > Human Nutrition Research Group
Publisher	American Society for Nutrition
Download/View statistics	View download statistics for this item

Download Statistics

Downloads

Downloads per month over past year

Deposit Details

Date Deposited:	30 Mar 2015 11:20	Date item deposited into CentAUR
Last Modified:	08 Sep 2024 06:38	Date item last modified

References

• Townsend N, Wickramasinghe K, Bhatnagar P, Smolina K, Nichols M, Leal J, Luengo-Fernandez R, Rayner M. Coronary heart disease statistics 2012 edition. British Heart Foundation London. 2012. • Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. • Ezzati M, Riboli E. Behavioral and Dietary Risk Factors for Noncommunicable Diseases. N Engl J Med 2013;369(10):954-64. doi: 10.1056/NEJMra1203528. • Chanet A, Milenkovic D, Manach C, Mazur A, Morand C. Citrus Flavanones: What Is Their Role in Cardiovascular Protection? J Agric Food Chem 2012;60(36):8809-22. doi: 10.1021/jf300669s. • Cassidy A, Rimm EB, O'Reilly ÉJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary Flavonoids and Risk of Stroke in Women. Stroke 2012;43(4):946-51. doi: 10.1161/strokeaha.111.637835. • Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong C-P, Nettleton JA, Jacobs DR. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85(3):895-909. • Mizrahi A, Knekt P, Montonen J, Laaksonen MA, Heliövaara M, Järvinen R. Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption. Br J Nutr 2009;102(07):1075-83. doi: 10.1017/S0007114509359097. • Steffen Y, Gruber C, Schewe T, Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 2008;469(2):209-19. doi: 10.1016/j.abb.2007.10.012. • Rizza S, Muniyappa R, Iantorno M, Kim Ja, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, et al. Citrus Polyphenol Hesperidin Stimulates Production of Nitric Oxide in Endothelial Cells while Improving Endothelial Function and Reducing Inflammatory Markers in Patients with Metabolic Syndrome. J Clin Endocrinol & Metab 2011;96(5):E782-E92. doi: 10.1210/jc.2010-2879. • Shen J, Nakamura H, Fujisaki Y, Tanida M, Horii Y, Fuyuki R, Takumi H, Shiraishi K, Kometani T, Nagai K. Effect of 4G-α-glucopyranosyl hesperidin on brown fat adipose tissue- and cutaneous-sympathetic nerve activity and peripheral body temperature. Neurosci Lett 2009;461(1):30-5. doi: 10.1016/j.neulet.2009.05.067. • Yamamoto M, Suzuki A, Hase T. Short-Term Effects of Glucosyl Hesperidin and Hesperetin on Blood Pressure and Vascular Endothelial Function in Spontaneously Hypertensive Rats. J Nutr Sci Vitaminol (Tokyo) 2008;54(1):95-8. doi: 10.3177/jnsv.54.95. • Jin Y-R, Han X-H, Zhang Y-H, Lee J-J, Lim Y, Chung J-H, Yun Y-P. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-γ2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 2007;194(1):144-52. doi: 10.1016/j.atherosclerosis.2006.10.011. • Morand C, Dubray C, Milenkovic D, Lioger D, Martin JFo, Scalbert A, Mazur A. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011;93(1):73-80. doi: 10.3945/ajcn.110.004945. • Vallejo F, Larrosa M, Escudero E, Zafrilla MP, Cerda B, Boza J, Garcia-Conesa MT, Espin JC, Tomas-Barberan FA. Concentration and Solubility of Flavanones in Orange Beverages Affect Their Bioavailability in Humans. J Agric Food Chem 2010;58(10):6516-24. doi: 10.1021/jf100752j. • Mullen W, Archeveque M-A, Edwards CA, Matsumoto H, Crozier A. Bioavailability and Metabolism of Orange Juice Flavanones in Humans: Impact of a Full-Fat Yogurt. J Agric Food Chem 2008;56(23):11157-64. doi: 10.1021/jf801974v. • Brett GM, Hollands W, Needs PW, Teucher B, R. Dainty J, Davis BD, Brodbelt JS, Kroon PA. Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion. Br J Nutr 2008;101(05):664. doi: 10.1017/s000711450803081x. • Roowi S, Mullen W, Edwards CA, Crozier A. Yoghurt impacts on the excretion of phenolic acids derived from colonic breakdown of orange juice flavanones in humans. Mol Nutr Food Res 2009;53(S1):S68-S75. doi: 10.1002/mnfr.200800287. • Pereira-Caro G, Borges G, van der Hooft J, Clifford MN, Del Rio D, Lean ME, Roberts SA, Kellerhals MB, Crozier A. Orange juice (poly)phenols are highly bioavailable in humans. Am J Clin Nutr 2014;100(5):1378-84. doi: 10.3945/ajcn.114.090282. • Ruano J, Lopez-Miranda J, Fuentes F, Moreno JA, Bellido C, Perez-Martinez P, Lozano A, Gómez P, Jiménez Y, Pérez Jiménez F. Phenolic Content of Virgin Olive Oil Improves Ischemic Reactive Hyperemia in Hypercholesterolemic Patients. J Am Coll Cardiol 2005;46(10):1864-8. doi: 10.1016/j.jacc.2005.06.078. • Rodriguez-Mateos A, Rendeiro C, Bergillos-Meca T, Tabatabaee S, George TW, Heiss C, Spencer JP. Intake and time dependence of blueberry flavonoid–induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am J Clin Nutr 2013;98(5):1179-91. doi: 10.3945/ajcn.113.066639. • British Cardiac Society BHS, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl 5):v1-v52. doi: 10.1136/hrt.2005.079988. • Jin MJ, Kim U, Kim IS, Kim Y, Kim D-H, Han SB, Kim D-H, Kwon O-S, Yoo HH. Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free Rats. J Toxicol Environ Health A 2010;73(21-22):1441-50. doi: 10.1080/15287394.2010.511549. • Westerhof BE, Gisolf J, Stok WJ, Wesseling KH, Karemaker JM. Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens 2004;22:1-10. • Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes Jr DR, Higano ST, Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003;41(10):1761-8. doi: 10.1016/S0735-1097(03)00329-2. • Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM. Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 2009;32(12):1079-85. doi: 10.1038/hr.2009.154. • Pucci G, Cheriyan J, Hubsch A, Hickson S, Gajendragadkar P, Watson T, O’Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson I, et al. Evaluation of theVicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens 2012;31(1):77-85. doi: 10.1097/HJH.0b013e32835a8eb1. • Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000;525(1):263-70. doi: 10.1111/j.1469-7793.2000.t01-1-00263.x. • Bahra M, Kapil V, Pearl V, Ghosh S, Ahluwalia A. Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide 2012;26(4):197-202. doi: 10.1016/j.niox.2012.01.004. • Zhang Q, Raheem KS, Botting NP, Slawin AMZ, Kay CD, O'Hagan D. Flavonoid metabolism: the synthesis of phenolic glucuronides and sulfates as candidate metabolites for bioactivity studies of dietary flavonoids. Tetrahedron 2012;68(22):4194-201. doi: 10.1016/j.tet.2012.03.100. • de Ferrars RM, Czank C, Saha S, Needs PW, Zhang Q, Raheem KS, Kroon PA, Kay CD. Methods for isolating, identifying and quantifying anthocyanin metabolites in clinical samples. Anal Chem 2014;86(20):10052-8. doi: 10.1021/ac500565a. • Krueger LA, Barnard MR, Frelinger Iii AL, Furman MI, Michelson AD. Immunophenotypic Analysis of Platelets. Edtion ed. Curr Protoc Cytom, 2002. • Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, Violi F. Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia. Arterioscler Thromb Vasc Biol 2010;30(2):360-7. doi: 10.1161/atvbaha.109.198622. • Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010;31(9):1142-8. doi: 10.1093/eurheartj/ehq010. • Jones B, Kenward MG. Design and Analysis of Cross-Over Trials (monographs on Statistics and Applied Probability 98). Second ed. London: CRC press, 2003. • Dhindsa M, Sommerlad SM, DeVan AE, Barnes JN, Sugawara J, Ley O, Tanaka H. Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol 2008;105(2):427-32. doi: 10.1152/japplphysiol.90431.2008. • Egert S, Wolffram S, Schulze B, Langguth P, Hubbermann EM, Schwarz K, Adolphi B, Bosy-Westphal A, Rimbach G, Muller MJ. Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules. Br J Nutr 2012;107(4):539-46. doi: 10.1017/S0007114511003242. • Onkelinx S, Cornelissen V, Goetschalckx K, Thomaes T, Verhamme P, Vanhees L. Reproducibility of different methods to measure the endothelial function. Vasc Med 2012;17(2):79-84. doi: 10.1177/1358863x12436708. • Lind L. Relationships between three different tests to evaluate endothelium-dependent vasodilation and cardiovascular risk in a middle-aged sample. J Hypertens 2013;31(8):1570-4. doi: 10.1097/HJH.0b013e3283619d50. • Fuchs D, de Graaf Y, van Kerckhoven R, Draijer R. Effect of tea theaflavins and catechins on microvascular function. Nutrients 2014;6(12):5772-85. doi: 10.3390/nu6125772.

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar